Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards

HONG KONG, Feb. 27, 2019 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX:01801), today announced that it received the International Finance Review (IFR) Asia-Pacific IPO of the Year 2018 …
( read original story …)

---